Is Q32 Bio Inc (QTTB) overvalued? · rev $53.7M
Q32 Bio Inc (QTTB) is a biotechnology company listed on US.
This page asks whether Q32 Bio Inc (QTTB) looks expensive on cached numbers — not a short thesis.
Latest reported QTTB revenue for 2025-12-31 was $53.7M. Net income was $29.8M. QTTB currently screens at market cap $32.4M.
QTTB currently screens at market cap $32.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next QTTB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the QTTB stock page for the full model, not this heading.
Not investment advice.